Objectives: To examine the effects of specific interventions on biosimilar glargine insulin (BGI) prescribing in general practices and to analyse the influence of prescriber and economic impact.
Design: Non randomized controlled study.
Setting: General practices in 2 health areas of Seville, intervention and control group.